These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2393768)

  • 61. The time from diagnostic excision biopsy to wide local excision for primary cutaneous malignant melanoma may not affect patient survival.
    McKenna DB; Lee RJ; Prescott RJ; Doherty VR
    Br J Dermatol; 2002 Jul; 147(1):48-54. PubMed ID: 12100184
    [TBL] [Abstract][Full Text] [Related]  

  • 62. N-ratio: a novel independent prognostic factor for patients with stage-III cutaneous melanoma.
    Rossi CR; Mocellin S; Pasquali S; Pilati P; Nitti D
    Ann Surg Oncol; 2008 Jan; 15(1):310-5. PubMed ID: 17987346
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Sentinel lymph node biopsy in the management of cutaneous head and neck melanoma.
    Carlson GW; Murray DR; Lyles RH; Hestley A; Cohen C
    Plast Reconstr Surg; 2005 Mar; 115(3):721-8. PubMed ID: 15731669
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Staging work-up and post-treatment surveillance of patients with melanoma.
    Olson JA; Jaques DP; Coit DG; Hwu WJ
    Clin Plast Surg; 2000 Jul; 27(3):377-90, viii. PubMed ID: 10941559
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The Association Between Excision Margins and Local Recurrence in 11,290 Thin (T1) Primary Cutaneous Melanomas: A Case-Control Study.
    MacKenzie Ross AD; Haydu LE; Quinn MJ; Saw RP; Shannon KF; Spillane AJ; Stretch JR; Scolyer RA; Thompson JF
    Ann Surg Oncol; 2016 Apr; 23(4):1082-9. PubMed ID: 26561405
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Risk factors for in-transit metastasis in patients with cutaneous melanoma].
    Clemente-Ruiz de Almiron A; Serrano-Ortega S
    Actas Dermosifiliogr; 2012 Apr; 103(3):207-13. PubMed ID: 21899829
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Factors predicting the risk of in-transit recurrence after sentinel lymphonodectomy in patients with cutaneous malignant melanoma.
    Kretschmer L; Beckmann I; Thoms KM; Mitteldorf C; Bertsch HP; Neumann C
    Ann Surg Oncol; 2006 Aug; 13(8):1105-12. PubMed ID: 16865591
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Conservative surgical management of superficially invasive cutaneous melanoma.
    Cosimi AB; Sober AJ; Mihm MC; Fitzpatrick TB
    Cancer; 1984 Mar; 53(6):1256-9. PubMed ID: 6692315
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Safe margins in the excision of primary cutaneous melanoma.
    Neades GT; Orr DJ; Hughes LE; Horgan K
    Br J Surg; 1993 Jun; 80(6):731-3. PubMed ID: 8330159
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Recurrence of cutaneous melanoma of the head and neck after negative sentinel lymph node biopsy.
    Davis-Malesevich MV; Goepfert R; Kubik M; Roberts DB; Myers JN; Kupferman ME
    Head Neck; 2015 Aug; 37(8):1116-21. PubMed ID: 24764188
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The management of cervical lymph nodes in patients with cutaneous melanoma.
    Martin RC; Shannon KF; Quinn MJ; Saw RP; Spillane AJ; Stretch JR; Colman MH; Gao K; Thompson JF
    Ann Surg Oncol; 2012 Nov; 19(12):3926-32. PubMed ID: 22669449
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Surgical treatment of malignant melanoma: practical guidelines.
    Levine SM; Shapiro RL
    Dermatol Clin; 2012 Jul; 30(3):487-501. PubMed ID: 22800553
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Prediction of sentinel lymph node micrometastasis by histological features in primary cutaneous malignant melanoma.
    Mraz-Gernhard S; Sagebiel RW; Kashani-Sabet M; Miller JR; Leong SP
    Arch Dermatol; 1998 Aug; 134(8):983-7. PubMed ID: 9722728
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Think before you shave: Factors influencing choice of biopsy technique for invasive melanoma and effect on definitive management.
    de Menezes SL; Wolfe R; Kelly JW; Farrugia H; Mar VJ
    Australas J Dermatol; 2020 May; 61(2):134-139. PubMed ID: 31869446
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Evolving treatment strategies in thin cutaneous head and neck melanoma: 1 institution's experience.
    Jaber JJ; Clark JI; Muzaffar K; Ruggiero FP; Feustel PJ; Frett MJ; Zender CA
    Head Neck; 2011 Jan; 33(1):7-12. PubMed ID: 20848424
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Stage-Based Detection Methods and Recurrence Patterns for Cutaneous Melanoma.
    Sullivan FG; Adler KB; Boudreaux MD; Hensley LM; Roberts ME; Liles JS; Howard JH
    Am Surg; 2024 Jul; 90(7):1963-1965. PubMed ID: 38549200
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The use of high resolution ultrasound in preoperative evaluation of cutaneous malignant melanoma thickness.
    Reali UM; Santucci M; Paoli G; Chiarugi C
    Tumori; 1989 Oct; 75(5):452-5. PubMed ID: 2690433
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A meta-analysis on the influence of partial biopsy of primary melanoma on disease recurrence and patient survival.
    Moscarella E; Pampena R; Palmiotti G; Bonamonte D; Brancaccio G; Piccolo V; Longo C; Argenziano G
    J Eur Acad Dermatol Venereol; 2020 Feb; 34(2):279-284. PubMed ID: 31441557
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Melanoma with rhabdomyosarcomatous features: a potential diagnostic pitfall.
    Watter H; Milkins R; Chambers C; O'Brien B
    BMJ Case Rep; 2023 Oct; 16(10):. PubMed ID: 37879714
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The Current Role of Surgery in the Treatment of Cardiac Metastases from Malignant Melanoma: an Educational Presentation.
    Spiliopoulos K; Engels P; Kimpouri K; Floudas I; Salemis NS; Schmid FX
    Braz J Cardiovasc Surg; 2021 Feb; 36(1):112-115. PubMed ID: 33438848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.